Mia's Feed
Medical News & Research

New Discovery Links Cancer Signaling Pathway to Blood-Brain and Blood-Retina Barrier Functions

New Discovery Links Cancer Signaling Pathway to Blood-Brain and Blood-Retina Barrier Functions

Share this article

Recent research uncovers a novel link between cancer signaling pathways, specifically MDM2-p53, and the regulation of blood-brain and blood-retina barriers, with implications for neurological and ocular health.

2 min read

A recent study led by researchers from the University of Minnesota Medical School has revealed a surprising connection between cancer-related cellular pathways and the vascular functions of the retina and the brain. The team found that the MDM2-p53 signaling axis, well-known for its role in tumor suppression, also plays a significant role in maintaining the integrity of blood vessels in the central nervous system, including the retina.

Published in Science Signaling, the research demonstrates that p53, a critical protein in cancer prevention, can influence blood vessel health by downregulating NCAPH, a protein involved in vascular stability. This interaction appears to weaken the Norrin/Frizzled4 signaling pathway, which is essential for the development and maintenance of blood-tissue barriers such as the blood-brain barrier and the blood-retina barrier.

Blood-CNS barriers are crucial in regulating the exchange of nutrients and waste between the bloodstream and the nervous system, preventing issues like edema and neuroinflammation. The study highlights that increasing p53 levels, a strategy used in some cancer therapies, might inadvertently compromise these barriers, potentially leading to increased vascular permeability, neuroinflammation, and swelling.

Furthermore, the research identifies NCAPH as a potential candidate gene for familial exudative vitreoretinopathy (FEVR), a rare inherited eye condition affecting retinal blood vessels. These findings suggest caution in using MDM2 inhibitors—drugs that elevate p53—in cancer treatment, as they could disrupt vascular barrier functions.

The study emphasizes the need for further research into how modulation of p53 may impact vascular health, especially in the context of neurological and ocular diseases. It also opens avenues for exploring NCAPH as a target for vascular disorder therapeutics.

For more information, see the full study: Jacklyn Levey et al, The MDM2-p53 axis regulates norrin/frizzled4 signaling and blood-CNS barrier function, Science Signaling (2025). For details, visit: https://medicalxpress.com/news/2025-07-uncovers-link-cancer-pathway-blood.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Virtual Trial Indicates Combination Rescue Inhaler Significantly Reduces Severe Asthma Attacks

A groundbreaking virtual trial demonstrates that adding an inhaled corticosteroid to rescue therapy nearly halves severe asthma attacks, offering new hope for mild asthma management.

Understanding Gene Expression Changes Post-Asbestos Exposure and Their Role in Malignant Mesothelioma Development

New research uncovers how asbestos-induced gene expression changes contribute to the development of malignant mesothelioma, offering potential pathways for diagnosis and targeted therapy.

Wildfires and Their Impact on Increasing Risks of Flu and COVID-19 Spread

Wildfires may increase the risk of flu and COVID-19 outbreaks by driving more people indoors, where airborne diseases can spread more easily. Wearing masks can help reduce this risk during wildfire seasons.